[HTML][HTML] Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
The B.1.1.529/Omicron variant of SARS-CoV-2 was only recently detected in southern Africa,
but its subsequent spread has been extensive, both regionally and globally 1 . It is …
but its subsequent spread has been extensive, both regionally and globally 1 . It is …
[HTML][HTML] Antibody resistance of SARS-CoV-2 variants B. 1.351 and B. 1.1. 7
The COVID-19 pandemic has had widespread effects across the globe, and its causative
agent, SARS-CoV-2, continues to spread. Effective interventions need to be developed to end …
agent, SARS-CoV-2, continues to spread. Effective interventions need to be developed to end …
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
T Dragic, V Litwin, GP Allaway, SR Martin, Y Huang… - Nature, 1996 - nature.com
The β-chemokines MIP-1α, MIP-1β and RANTES inhibit infection of CD4 + cells by primary,
non-syncytium-inducing (NSI) HIV-1 strains at the virus entry stage, and also block env-…
non-syncytium-inducing (NSI) HIV-1 strains at the virus entry stage, and also block env-…
[HTML][HTML] Antibody evasion properties of SARS-CoV-2 Omicron sublineages
The identification of the Omicron (B. 1.1. 529.1 or BA. 1) variant of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) in Botswana in November 2021 1 immediately …
syndrome coronavirus 2 (SARS-CoV-2) in Botswana in November 2021 1 immediately …
[HTML][HTML] Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic continues,
with devasting consequences for human lives and the global economy 1 , 2 . The discovery …
with devasting consequences for human lives and the global economy 1 , 2 . The discovery …
[HTML][HTML] Antibody evasion by SARS-CoV-2 Omicron subvariants BA. 2.12. 1, BA. 4 and BA. 5
SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 have surged notably to become
dominant in the United States and South Africa, respectively 1 , 2 . These new subvariants …
dominant in the United States and South Africa, respectively 1 , 2 . These new subvariants …
[PDF][PDF] Increased resistance of SARS-CoV-2 variant P. 1 to antibody neutralization
The emergence of SARS-CoV-2 variants has raised concerns about altered sensitivity to
antibody-mediated immunity. The relative resistance of SARS-CoV-2 variants B.1.1.7 and B.…
antibody-mediated immunity. The relative resistance of SARS-CoV-2 variants B.1.1.7 and B.…
The role of a mutant CCR5 allele in HIV–1 transmission and disease progression
A 32–nucleotide deletion (δ32) within the β–chemokine receptor 5 (CCR5) gene has been
described in subjects who remain uninfected despite extensive exposure to HIV–1. This allele …
described in subjects who remain uninfected despite extensive exposure to HIV–1. This allele …
[PDF][PDF] A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids
…, M Cioffi, V Chandar, DA Hoagland, Y Huang… - Cell stem cell, 2020 - cell.com
SARS-CoV-2 has caused the COVID-19 pandemic. There is an urgent need for physiological
models to study SARS-CoV-2 infection using human disease-relevant cells. COVID-19 …
models to study SARS-CoV-2 infection using human disease-relevant cells. COVID-19 …
[PDF][PDF] Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite
…, ER Reddem, J Yu, F Bahna, J Bimela, Y Huang… - Cell host & …, 2021 - cell.com
Numerous antibodies that neutralize SARS-CoV-2 have been identified, and these generally
target either the receptor-binding domain (RBD) or the N-terminal domain (NTD) of the viral …
target either the receptor-binding domain (RBD) or the N-terminal domain (NTD) of the viral …